2-Dec-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Medicine
Gastroenterology...
Small Intestine
Browse
ALL OF MEDICINE
Gastroenterology & Hepatology
Biliary Tract
Clinical Nutrition
Colon & Rectum
Disorders of Neurogastroenterology & Motility
Endoscopy
Esophagus
Gastrointestinal Cancers
Gastrointestinal Infections
Inflammatory Bowel Disease
Liver Biology & Pathobiology
Liver Failure & Liver Disease
Pancreas
Small Intestine
Stomach & Duodenum
Related Sections
Diabetes & Obesity
Renal & Gastrointestinal Problems in Critical Care
selected for
My F1000 Medicine
Browse > Gastroenterology & Hepatology > Small Intestine
Current Top 10 by F1000 Factor
/
All Time Top 10 by F1000 Factor
/
Most viewed
(from all journals)
/
Most viewed
(from specialty journals)
/
Hidden jewels
Page 1 of 6. Select Page:
1
2
3
4
5
6
>>
Display
10
/
20
/
50
papers per page
printer friendly
10 per page
20 per page
50 per page
any date
past 7d
past 14d
past 30d
past 60d
past 90d
past 180d
past 1y
past 2y
past 5y
all papers
hypotheses
new findings
confirmations
tech advances
controversial
refutation
dissenting
new on F1000
newly evaluated
F1000 factor
most evaluations
this page
selected articles
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
Recommended
F1000 Factor
3.0
Controversial
Predicting relapse in Crohn's disease: a biopsychosocial model.
Bitton A, Dobkin PL, …, Franchimont D, Wild GE
Gut
2008 Oct
57
(10):1386-92 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Ingvar Bjarnason
Evaluated 28 Nov 2008
Recommended
F1000 Factor
3.0
Hypothesis
New Finding
Controversial
Esomeprazole induces upper gastrointestinal tract transmucosal permeability (R2).
Mullin JM, Valenzano MC, …, Mercogliano G, Thornton AJ
Aliment Pharmacol Ther
2008 Aug 4
28
[
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Ingvar Bjarnason
Evaluated 27 Nov 2008
Recommended
F1000 Factor
3.0
Confirmation
New Finding
Usefulness of double-balloon endoscopy in the diagnosis of malignant small-bowel tumors.
Yamagami H, Oshitani N, …, Fujiwara Y, Arakawa T
Clin Gastroenterol Hepatol
2008 Nov
6
(11):1202-5 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Marco Pennazio
Evaluated 17 Nov 2008
Recommended
F1000 Factor
3.0
Confirmation
Hypothesis
A multicenter randomized comparison of the Endocapsule and the Pillcam SB.
Cave DR, Fleischer DE, …, Lee M, Bhattacharya K
Gastrointest Endosc
2008 Sep
68
(3):487-94 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Nigel Umar Beejay
Evaluated 28 Oct 2008
Recommended
F1000 Factor
3.0
Changes
Clinical Practice
New Finding
Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years.
Friedman S, Rubin PH, …, Harpaz N, Present DH
Clin Gastroenterol Hepatol
2008 Sep
6
(9):993-8; quiz 953-4 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Maria Abreu with Paul A Feldman
Evaluated 27 Oct 2008
Must Read
F1000 Factor
6.0
Confirmation
New Finding
Tech Advance
Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs.
Rogers CS, Stoltz DA, …, Prather RS, Welsh MJ
Science
2008 Sep 26
321
(5897):1837-41 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Nicola Jones with Séamus Hussey
Evaluated 24 Oct 2008
Must Read
F1000 Factor
6.4
Hypothesis
New Finding
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease.
Kaser A, Lee AH, …, Glimcher LH, Blumberg RS
Cell
2008 Sep 5
134
(5):743-56 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Tor Savidge / Eduard Stange
First evaluation 7 Oct 2008 | Latest evaluation 12 Oct 2008
Recommended
F1000 Factor
3.0
Changes
Clinical Practice
Confirmation
Predictors of family risk for celiac disease: a population-based study.
Rubio-Tapia A, Van Dyke CT, …, Melton LJ, Murray JA
Clin Gastroenterol Hepatol
2008 Sep
6
(9):983-7 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Karel Geboes
Evaluated 1 Oct 2008
Recommended
F1000 Factor
3.0
New Finding
Controversial
Clinical trial: protective effect of a commercial fish protein hydrolysate against indomethacin (NSAID)-induced small intestinal injury.
Marchbank T, K Limdi J, …, Elia G, J Playford R
Aliment Pharmacol Ther
2008 Jun 26 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Ingvar Bjarnason
Evaluated 30 Sep 2008
Recommended
F1000 Factor
3.0
Confirmation
New Finding
Enterochromaffin Cell Hyperplasia in Irritable Pouch Syndrome.
Shen B, Liu W, …, Bambrick ML, Fazio VW
Am J Gastroenterol
2008 Aug 10 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| John Mclaughlin with Gordon W Moran
Evaluated 29 Sep 2008
top of page
Page 1 of 6. Select Page:
1
2
3
4
5
6
>>
Display
10
/
20
/
50
papers per page
© 2008 Medicine Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info